MARKET

GCTK

GCTK

Glucotrack
NASDAQ
1.740
+0.190
+12.26%
After Hours: 1.600 -0.14 -8.05% 19:56 02/06 EST
OPEN
1.530
PREV CLOSE
1.550
HIGH
1.770
LOW
1.523
VOLUME
153.38K
TURNOVER
--
52 WEEK HIGH
127.80
52 WEEK LOW
1.523
MARKET CAP
1.58M
P/E (TTM)
-0.0014
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at GCTK last week (0126-0130)?
Weekly Report · 5d ago
12 Health Care Stocks Moving In Thursday's Intraday Session
Benzinga · 01/29 17:05
GlucoTrack Strengthens IP for Implantable Glucose Monitoring Platform
TipRanks · 01/29 15:01
The US Patent and Trademark Office has issued Patents For Glucotrack's Continuous Blood Glucose Monitoring Platform
Benzinga · 01/29 13:06
GlucoTrack Secures USPTO Patents for Fully Implantable Continuous Blood Glucose Monitoring System
Reuters · 01/29 13:02
Glucotrack Announces USPTO Approval for Issuance of Patents for Proprietary CBGM Platform
Barchart · 01/29 07:01
Weekly Report: what happened at GCTK last week (0119-0123)?
Weekly Report · 01/26 09:34
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Benzinga · 01/21 12:05
More
About GCTK
Glucotrack, Inc. is focused on the design, development, and commercialization of technologies for people with diabetes. The Company is engaged in developing a long-term Implantable Continuous Blood Glucose Monitor (CBGM) for people living with Type 1 diabetes and insulin-dependent Type 2 diabetes. Its CBGM is a long-term, implantable system that continually measures blood glucose levels with a sensor longevity of 3 years, no on-body wearable component and with minimal calibration. Its CBGM technology allows for a less burdensome approach to glucose monitoring. It has also completed four animal studies with evolving prototype systems, all four of which consistently demonstrated a simple implant procedure, functionality, and safety. The Company has also demonstrated continuous glucose sensing in the epidural space via two additional animal trials, both of which demonstrated a simple implant procedure, functionality, and safety.

Webull offers GlucoTrack Inc stock information, including NASDAQ: GCTK real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, GCTK stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading GCTK stock methods without spending real money on the virtual paper trading platform.